Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.
about
Self-monitoring and self-management of oral anticoagulationAssessing bleeding risk in patients taking anticoagulantsEvidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesVTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesAntithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesDiagnosis and treatment of deep-vein thrombosisAnticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive studySelf-monitoring and self-management of oral anticoagulationManagement of Venous Thromboembolisms: Part I. The Consensus for Deep Vein ThrombosisVenous thromboembolism: Predicting recurrence and the need for extended anticoagulationRecurrent venous thromboembolism: what is the risk and how to prevent itPredicting the risk of venous thromboembolism recurrenceReview article: Venous thromboembolism after total joint replacementChronic thromboembolic pulmonary hypertension: Medical treatment.Guidance for the treatment of deep vein thrombosis and pulmonary embolismDuration of anticoagulation for venous thromboembolic eventsGuidelines on oral anticoagulation with warfarin - fourth editionPulmonary embolism in hospital practice.Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review.The role of ximelagatran in the treatment of venous thromboembolism.Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study.Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.Thrombosis in small and medium-sized pulmonary arteries in Wegener's granulomatosis: a confocal laser scanning microscopy study.Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic reviewResidual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study.Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trialsSafe use of antithrombotics for stroke prevention in atrial fibrillation: consideration of risk assessment tools to support decision-makingTargeted gene sequencing identifies variants in the protein C and endothelial protein C receptor genes in patients with unprovoked venous thromboembolism.Evolving use of new oral anticoagulants for treatment of venous thromboembolismImpact of age, CYP2C9 genotype and concomitant medication on the rate of rise for prothrombin time during the first 30 days of warfarin therapy.A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population.Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis.Guidelines on oral anticoagulation (warfarin): third edition--2005 update.Trial Protocol: a randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovokedGenetic determinants of response to warfarin during initial anticoagulationOptimal duration of anticoagulation after venous thromboembolism.Efficacy and safety of new oral anticoagulants for extended treatment of venous thromboembolism: systematic review and meta-analyses of randomized controlled trials.Low-intensity adjusted-dose warfarin for the prevention of hemodialysis catheter failure: a randomized, controlled trial.
P2860
Q24235798-576F35AD-FBE4-465E-B368-2E1C15370774Q24619070-8901EBA0-EE06-4B0D-8198-E5115065D27FQ24632951-C9E595E4-003A-47E2-8F42-74E1F4D21A8AQ24632982-8486AD6C-77D0-4F78-81E5-E565B8ED8C39Q24633053-A0BC3FFE-4B42-4074-8216-FFE60B5CE8CDQ24673847-56DC3872-35F5-49D0-B2A6-1A0AF6ED3D6AQ25257138-A1F33A48-AE25-4AFC-9DAC-2D4528929332Q26471166-66F85A80-BC6E-4D91-B23A-00C4E0AC7307Q26749273-70C2BECA-A4A2-451A-BFB5-1BC8EBACDB7EQ26825608-EAC631A0-499B-4F33-B909-58960BCB9B4EQ26826847-D67C920A-585D-45FC-8A8A-834273B8C1A2Q26865059-B0E42433-F1D6-4618-B380-7414E5F33309Q27006824-28A4346D-B2CA-4132-9DC0-25B5BDC44611Q27687768-2A6A96B0-5E2F-49BF-9B88-055657B50433Q28078989-BFB9EE81-D32F-42F0-A80C-936309A6F1CAQ28081375-77B7A5CA-AABF-4F23-95C9-42F27123195CQ28240666-03D5A82F-A887-4530-AFD8-BFAEBE48F1C7Q30476617-63BF4693-7E67-4359-BA48-D98DE7FB4731Q33348847-0E943CB3-0C66-4366-8B3C-0B8A94A9A3CCQ33369274-84902247-D0F2-4684-AF8A-C07786722436Q33685299-20A187FF-2870-4848-99EF-A55D31B3D0F0Q33755738-97004235-B7F8-4899-AA37-D96B41FA2D31Q33790855-7C4D1ED7-1A83-4C10-B9C4-E463ADC6245BQ33795571-76B7E3CD-5913-4BDE-9305-E81D5FB8EDF2Q33821311-B921A5A9-D795-4D8E-B8C8-C4152A0A4777Q33910755-8FB93AA6-31F2-4D45-BAA9-FD01DFB1BA0FQ33949571-0B5AB6A0-3E60-4EC2-8172-82A120FDD367Q33973390-409667BD-AEFB-4AC3-BCB2-EF6785E196BAQ34047821-B45B626F-1C8A-40AC-95F5-028C8EDA0BD1Q34146486-EA10C717-07C1-455B-A821-7D9FE783E5E8Q34200483-F025FA4A-13D7-4C4D-8761-771266B52B49Q34252907-D74D3794-3836-48DF-A805-DD4F58609688Q34362277-4AAED7F3-E51D-484E-BDD3-B49B3EE6472EQ34437785-B20A2F37-BAD6-4EAB-BB65-26D77B884C0AQ34484090-2A70C397-0D56-4D71-B32D-841FC4FC9235Q34623435-57920932-27AE-4965-A6E8-E9CA1C71A560Q34759038-AD5A0E4B-6AF7-4093-8B49-7C63B1EA8024Q34781477-1EC48084-FE75-44A7-8E2B-12F09C826D3FQ34787240-3AAF75BE-BA32-45C8-BFD6-87066614B2A1Q34926806-FCFC3508-6F73-4722-A5EA-80CA8216D646
P2860
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Comparison of low-intensity wa ...... urrent venous thromboembolism.
@en
Comparison of low-intensity wa ...... urrent venous thromboembolism.
@nl
type
label
Comparison of low-intensity wa ...... urrent venous thromboembolism.
@en
Comparison of low-intensity wa ...... urrent venous thromboembolism.
@nl
prefLabel
Comparison of low-intensity wa ...... urrent venous thromboembolism.
@en
Comparison of low-intensity wa ...... urrent venous thromboembolism.
@nl
P2093
P356
P1476
Comparison of low-intensity wa ...... urrent venous thromboembolism.
@en
P2093
Alexander G Turpie
Betsy MacKinnon
Christine Demers
Clive Kearon
David R Anderson
Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators
Jeannine Kassis
Jeffrey I Weitz
Jeffrey S Ginsberg
Jim A Julian
P304
P356
10.1056/NEJMOA035422
P407
P577
2003-08-01T00:00:00Z